PATENT CLAIM ANALYSIS

Application Number: 16078431
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-03
Patent Classification: ["514", "304000"]

Abstract:
The invention provides methods for modulating the activity of farnesoid X receptors (FXRs) using specific FXR agonists, in particular for treating or preventing liver diseases and disorders.

Claim (Index 2):
The method according to  claim 1 , wherein the disease is a cholestatic disorder including cholestasis (e.g. intrahepatic cholestasis, estrogen-induced cholestasis, drug-induced cholestasis, cholestasis of pregnancy, parenteral nutrition-associated cholestasis), primary biliary cholangitis (PBC), cirrhosis, primary sclerosing cholangitis (PSC), progressive familiar cholestatis (PFIC), Alagille syndrome, biliary atresia, ductopenic liver transplant rejection, or cystic fibrosis liver disease.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 96.0
- Lexical Diversity: 1.03333
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14012401', '11819517', '15263033', '16030141', '14743295']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7788019319708169
- 35 USC 102 Novelty (BERT): 0.5115939013160836
- Combined Prediction Score: 0.7520811289053435
- Mean Citation Score: 248.90263
- Max Citation Score: 260.66025
- Similarity Product: 168.74461538091302

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test